Literature DB >> 11531409

The bet gene of feline foamy virus is required for virus replication.

A Alke1, A Schwantes, K Kido, M Flötenmeyer, R M Flügel, M Löchelt.   

Abstract

Foamy viruses (FV) are complex retroviruses with additional bel genes located between env and the 3' long-terminal repeat. The functions of the bel 2 and bet genes are unknown and both are dispensable for replication of the prototypic human foamy virus in cell cultures. We examined the function(s) of bel 2 and bet of the distantly related feline foamy virus (FFV) in the proviral context. Mutagenesis was used to alter the Bel 2 and Bet or to abrogate their expression. The Bel 2/Bet mutants showed a 1000-fold reduced viral titer in feline kidney cells; in human 293T cells, viral titer was only about 10-fold reduced compared to wild-type FFV. In both cell types, the Bel 2/Bet mutations resulted in a reduced release of FFV particles. The results indicate that FFV Bet is required for efficient virus replication. The functions of the Bel 2 and Bet proteins are discussed. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11531409     DOI: 10.1006/viro.2001.1065

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  26 in total

1.  Species-specific inhibition of APOBEC3C by the prototype foamy virus protein bet.

Authors:  Mario Perkovic; Stanislaw Schmidt; Daniela Marino; Rebecca A Russell; Benjamin Stauch; Henning Hofmann; Ferdinand Kopietz; Björn-Philipp Kloke; Jörg Zielonka; Heike Ströver; Johannes Hermle; Dirk Lindemann; Vinay K Pathak; Gisbert Schneider; Martin Löchelt; Klaus Cichutek; Carsten Münk
Journal:  J Biol Chem       Date:  2008-12-12       Impact factor: 5.157

Review 2.  APOBECs and virus restriction.

Authors:  Reuben S Harris; Jaquelin P Dudley
Journal:  Virology       Date:  2015-03-26       Impact factor: 3.616

3.  Reactivation of a complex retrovirus is controlled by a molecular switch and is inhibited by a viral protein.

Authors:  Christopher D Meiering; Maxine L Linial
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-01       Impact factor: 11.205

Review 4.  Role of the single deaminase domain APOBEC3A in virus restriction, retrotransposition, DNA damage and cancer.

Authors:  Yaqiong Wang; Kimberly Schmitt; Kejun Guo; Mario L Santiago; Edward B Stephens
Journal:  J Gen Virol       Date:  2015-10-20       Impact factor: 3.891

5.  Intra- and intercellular trafficking of the foamy virus auxiliary bet protein.

Authors:  Charles-Henri Lecellier; Wim Vermeulen; Françoise Bachelerie; Marie-Lou Giron; Ali Saïb
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

6.  Identification and functional characterization of Bet protein as a negative regulator of BFV3026 replication.

Authors:  Tiejun Bing; Kai Wu; Xiaoxu Cui; Peng Shao; Qicheng Zhang; Xiaobo Bai; Juan Tan; Wentao Qiao
Journal:  Virus Genes       Date:  2014-03-11       Impact factor: 2.332

7.  Furin-mediated cleavage of the feline foamy virus Env leader protein.

Authors:  Verena Geiselhart; Patrizia Bastone; Tore Kempf; Martina Schnölzer; Martin Löchelt
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

8.  The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein.

Authors:  Martin Löchelt; Fabian Romen; Patrizia Bastone; Heide Muckenfuss; Nadine Kirchner; Yong-Boum Kim; Uwe Truyen; Uwe Rösler; Marion Battenberg; Ali Saib; Egbert Flory; Klaus Cichutek; Carsten Münk
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-23       Impact factor: 11.205

Review 9.  Immunising with the transmembrane envelope proteins of different retroviruses including HIV-1: a comparative study.

Authors:  Joachim Denner
Journal:  Hum Vaccin Immunother       Date:  2012-12-18       Impact factor: 3.452

10.  Lentivirus restriction by diverse primate APOBEC3A proteins.

Authors:  Kimberly Schmitt; Kejun Guo; Miki Katuwal; Darayu Wilson; Courtney Prochnow; Ronda Bransteitter; Xiaojiang S Chen; Mario L Santiago; Edward B Stephens
Journal:  Virology       Date:  2013-05-04       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.